A Arribi

502 citations
20 papers · 361 · h-index 7

Impact in

Papers in

    • Antifungal resistance and susceptibility 9
    • Clostridium difficile and Clostridium perfringens research 2
    • Nail Diseases and Treatments 5
    • Fungal Infections and Studies 5

A Arribi

19 papers receiving 346 citations

Peers

A Arribi
Comparison fields: 5 of 62
  • Microbiology 16
  • Molecular Medicine 68
  • Clinical Biochemistry 91
  • Infectious Diseases 238
  • Applied Microbiology and Biotechnology 14
Replace Masahiro Toyokawa with:
Masahiro Toyokawa Japan
Katherine M. Riebe United States
Laura Maccacaro Italy
Karine Soetaert Belgium
Nadya Andini United States
Rebecca Jennemann United States
Lumyai Wonglakorn Thailand
Dongke Chen China
Isabel Fernández-Natal Spain
Paulo R. Cortes Argentina
A Arribi relative to Masahiro Toyokawa Japan Masahiro Toyokawa's profile →
Citations per field
00.5×1.5×2.2×
Masahiro Toyokawa · 1×
Citations per year

Countries citing papers authored by A Arribi

Since Specialization
Citations

This map shows the geographic impact of A Arribi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Arribi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Arribi more than expected).

Fields of papers citing papers by A Arribi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Arribi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Arribi. The network helps show where A Arribi may publish in the future.

Co-authors

The 25 scholars most cited alongside A Arribi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Arribi Line = papers co-authored together A Arribi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2010233
2 200942
3 202322
4 201912
5 201412
6
How should we approach Aspergillus in lung secretions of patients with COPD?
20168
7
[Five cases of zygomycosis.].
19996
8
[Bipolaris australiensis in a Spanish patient with allergic chronic sinusitis].
19974
9
[Factors of pathogenicity, biotype, serotype and antimicrobial sensitivity of 150 clinical isolates of Yersinia enterocolitica (1992-1994)].
19964
10
[Scedosporium apiospermum external otitis.].
19994
11
Estudio piloto de utilización de antifúngicos sistémicos en el Hospital Clínico San Carlos. Propuesta de un nuevo método de estudio
20093
12 20102
13
[Pilot Drug Utilization Study of systemic antifungal agents in the Hospital Clínico San Carlos. Proposal of a study method].
20092
14
[Invasive maxilar sinusitis by Rhizopus oryzae].
19972
15
Tinea capitis de importación en un niño guineano.
19981
16
[Psoas abscess caused Actinomyces israelii].
19991
17
[Candidemia and cutaneous lesions in two patients without intravenous drug addiction.].
19991
18
[Need for systematic HIV serological study during pregnancy].
19981
19
[Bacteremia caused by Shewanella putrefaciens].
19971
20
[Female with erythematous papular lesions of the leg].
19970

About A Arribi

A Arribi is a scholar working on Infectious Diseases, Epidemiology, Small Animals, Otorhinolaryngology and Dermatology, having authored 20 papers that have together received 361 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Nail Diseases and Treatments (5 papers), Fungal Infections and Studies (5 papers), Infectious Diseases and Mycology (5 papers), Actinomycetales infections and treatment (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Microbiology (16 citations), Molecular Medicine (68 citations), Clinical Biochemistry (91 citations), Infectious Diseases (238 citations) and Applied Microbiology and Biotechnology (14 citations). A Arribi has collaborated with scholars based in Spain, United Kingdom and Brazil. Frequent co-authors include Francisco Javier Candel, Elvira Baos, Miguel Sánchez García, Juan J. Picazo, J. Fereres, Gracia Morales, Paloma Merino, S. Puente, Alicia Gómez‐López and María José Buitrago. Their work appears in journals such as Journal of Clinical Pathology, Clinical Infectious Diseases, Medical Mycology, Advanced Functional Materials and Actas Dermo-Sifiliográficas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact